This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Revision Total Knee Arthroplasty, Revision Total Hip Arthroplasty or Acute Blood Loss Anemia
and you are
over 18
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

To determine the optimal dosing regimen and route of administration of tranexamic acid (TXA) [single dose intravenous (IV), double dose intravenous, intravenous + topical, and oral repeated dosing] to minimize post-operative blood loss and transfusion requirements following revision total knee arthroplasty (RTKA).

Provided treatments

  • Procedure: Revision Total Knee Arthroplasty (TKA)
  • Procedure: Revision Total Hip Arthroplasty (THA)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02877381. The sponsor of the trial is Rush University Medical Center and it is looking for 175 volunteers for the current phase.
Official trial title:
Tranexamic Acid in Revision Total Joint Arthroplasty: A Prospective Randomized Controlled Trial